Actively Recruiting
Observational Study of Adults with Polycystic Kidney Disease to Build a Clinical and Biological Research Database
Led by University of Maryland, Baltimore · Updated on 2025-09-11
350
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating autosomal dominant polycystic kidney disease ADPKD by establishing a Mid-Atlantic cohort of 350 adults with this condition. The study aims to support high-quality clinical and translational research by collecting detailed clinical information and biological samples. It focuses on understanding the progression of ADPKD and developing a collaborative network to facilitate future studies and trials. This observational study involves thorough baseline clinical assessments including kidney function, total kidney volume, family and clinical history, cardiac function, vascular stiffness, and quality of life. Biological samples such as serum, plasma, urine, and DNA will be collected to create a biobank. No treatments or interventions are given, and an electronic registry will be maintained to support future research participation. Participants will undergo baseline and follow-up assessments over at least three years, including MRI scans to measure kidney volume and annual quality of life evaluations. The study will track the development of ADPKD complications and changes in symptoms. This ongoing observation will help researchers understand the disease better, with no direct treatment involved. The total duration for participation will extend up to three years with regular evaluations.
CONDITIONS
Brief Title
PKD Clinical and Translational Core Study
Research Team
C
Charalett E Diggs, RN, MSN
K
Karkleen Schuhart
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here